Literature DB >> 32500957

No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial.

Brendan Smyth1,2,3, Li Zuo4, Nicholas A Gray5,6, Christopher T Chan7, Janak R de Zoysa8,9, Daqing Hong10,11, Kris Rogers1,12, Jia Wang11,13, Alan Cass14, Martin Gallagher1,15, Vlado Perkovic1, Meg Jardine1,15.   

Abstract

AIM: Extended hours haemodialysis is associated with superior survival to standard hours. However, residual confounding limits the interpretation of this observation. We aimed to determine the effect of a period of extended hours dialysis on long-term survival among participants in the ACTIVE Dialysis trial.
METHODS: Two-hundred maintenance haemodialysis recipients were randomized to extended hours dialysis (median 24 h/wk) or standard hours dialysis (median 12 h/wk) for 12 months. Further pre-specified observational follow up occurred at 24, 36 and 60 months. Vital status and modality of renal replacement therapy were ascertained.
RESULTS: Over the 5 years, 38 participants died, 30 received a renal transplant, and 6 were lost to follow up. Total weekly dialysis hours did not differ between standard and extended groups during the follow-up period (14.1 hours [95%CI 13.4-14.8] vs 14.8 hours [95%CI 14.1-15.6]; P = .16). There was no difference in all-cause mortality (hazard ratio for extended hours 0.91 [95%CI 0.48-1.72]; P = .77). Similar results were obtained after censoring participants at transplantation, and after adjusting for potential confounding variables. Subgroup analysis did not reveal differences in treatment effect by region, dialysis setting or vintage (P-interaction .51, .54, .12, respectively).
CONCLUSION: Twelve months of extended hours dialysis did not improve long-term survival nor affect dialysis hours after the intervention period. An urgent need remains to further define the optimal dialysis intensity across the broad range of dialysis recipients.
© 2020 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  dialysis; end-stage kidney disease; haemodialysis; mortality; randomized controlled trial

Mesh:

Year:  2020        PMID: 32500957     DOI: 10.1111/nep.13737

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  3 in total

1.  Analysis of inflammatory factor levels in serum and risk factors in patients with chronic renal failure undergoing maintenance hemodialysis.

Authors:  Min Zhou; Yuan Du; Yanping Wu; Ping Zhang; Peng Liu; Jiarui Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis.

Authors:  Melissa Nataatmadja; Rathika Krishnasamy; Li Zuo; Daqing Hong; Brendan Smyth; Min Jun; Janak R de Zoysa; Kirsten Howard; Jing Wang; Chunlai Lu; Zhangsuo Liu; Christopher T Chan; Alan Cass; Vlado Perkovic; Meg Jardine; Nicholas A Gray
Journal:  Kidney Int Rep       Date:  2021-02-01

3.  Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study.

Authors:  James Fotheringham; Nicholas Latimer; Marc Froissart; Florian Kronenberg; Peter Stenvinkel; Jürgen Floege; Kai-Uwe Eckardt; David C Wheeler
Journal:  Clin Kidney J       Date:  2020-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.